All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
A Retrospective Policy Analysis of FDA’s CPG 400.400
The origins of FDA's CPG 400.400 go back to a series of meetings between industry and Agency enforcement personnel in the 1980s. The resulting CPG...
The Regulation of Homeopathic Drug Products
Statutory Recognition of Homeopathic Drugs Since the passage of the Federal Food, Drug, and Cosmetic Act (FDCA) in 1938, homeopathic drugs are the only form...
AAHP Annual Meeting, Report Recap and Election Results.
The AAHP held the annual membership meeting in Mid-March. The largest number of people attended this meeting than any other in the association's history. In...
Regulation in Homeopathy
This month we will discuss policy outcomes from FDA's policy and enforcement guidance documents past and present for homeopathic drug products. In our first article,...
Snapshots From There and Then: History of Homeopathy
In honor of AAHP's 100th anniversary year, we look back at the history of homeopathy to find how this medical modality spread around the world....
Three Changes Proposed in 2024 Federal Budget that Could Affect Homeopathic Manufacturers
President Biden unveiled his 2024 Federal Budget Proposal on March 9, 2023. AAHP is highlighting three items that could impact homeopathic manufacturers. These items are...
Homeopathic Basic Research: Building on the Past and Imaging the Future
A team of European researchers undertook a three-part study to evaluate existing research entitled, "Physicochemical Investigations of Homeopathic Preparations: A Systematic Review and Bibliometric Analysis."...
